ESR1 and breast cancer: The differences in BCSS probability between the groups were significant: for the ER+HER2– BC subgroup, p-values were < 0.0001 for the low vs. high, 0.0096 for the low vs. intermediate, and < 0.0001 for the intermediate vs. high-risk subgroup.